Literature DB >> 4036981

Plasma cell dyscrasia with marrow fibrosis. Clinicopathologic syndrome.

L Vandermolen, L Rice, E C Lynch.   

Abstract

Five new cases of plasma cell dyscrasia with coexistent myelofibrosis are described and six previously reported cases are reviewed. Four of the new patients and two from the literature had features of a previously unrecognized syndrome. This syndrome was characterized by significant paraprotein levels, marked marrow fibrosis, and plasmacytosis, without features of extramedullary hematopoiesis (agnogenic myeloid metaplasia) and leukoerythroblastosis. These patients were generally severely anemic and commonly leukopenic and thrombocytopenic. In contrast, one of the new patients and four in the literature showed classic features of the myeloproliferative disease, myelofibrosis with agnogenic myeloid metaplasia, along with features of typical multiple myeloma.

Entities:  

Mesh:

Year:  1985        PMID: 4036981     DOI: 10.1016/0002-9343(85)90307-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

1.  Bone marrow biopsy in monoclonal gammopathies: correlations between pathological findings and clinical data. The Cooperative Group for Study and Treatment of Multiple Myeloma.

Authors:  A Riccardi; G Ucci; R Luoni; A Castello; A Coci; U Magrini; E Ascari
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

2.  Frequent association of idiopathic myelofibrosis with plasma cell dyscrasias.

Authors:  U Dührsen; M Uppenkamp; P Meusers; E König; G Brittinger
Journal:  Blut       Date:  1988-03

3.  Primary plasma cell leukemia with extensive dense osteosclerosis: complete remission following combination chemotherapy.

Authors:  M C Kuo; L Y Shih
Journal:  Ann Hematol       Date:  1995-09       Impact factor: 3.673

4.  Plasma cell leukemia with myelofibrosis.

Authors:  T Murayama; T Matsui; Y Hayashi; T Taniguchi; M Ito; T Natazuka; S Imoto; N Iwata; T Isobe; H Ito
Journal:  Ann Hematol       Date:  1994-09       Impact factor: 3.673

5.  Coexistence of plasma cell dyscrasia with prefibrotic stage of primary myelofibrosis: a case report.

Authors:  George Tsirakis; Peggy Kanellou; Maria Kaparou; Andrew Passam; Amalia Zampoulaki; Kostas Stylianou; Michael G Alexandrakis
Journal:  ISRN Hematol       Date:  2011-05-19

6.  The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors.

Authors:  Barry Paul; Yue Zhao; Gavin Loitsch; Daniel Feinberg; Parker Mathews; Ian Barak; Megan Dupuis; Zhiguo Li; Lindsay Rein; Endi Wang; Yubin Kang
Journal:  Cancer Med       Date:  2020-07-06       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.